Cite

    Baulac, M. et al. (n.d.). Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Lancet neurology. 16 (1), pp. 43-54. [Online].